Unveiling the Synergistic Potential: Bispecific Antibodies in Conjunction with Chemotherapy for Advanced Non-Small-Cell Lung Cancer Treatment
Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small-cell lung cancer (NSCLC) accounting for the majority of the cases. Despite advancements in targeted therapies and immunotherapies, many patients still rely on chemotherapy, highlighting the need for innovativ...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-03-01
|
| Series: | Current Oncology |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1718-7729/32/4/206 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|